Kemper CA - Search Results

1

A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.

Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group 578 Study Team. Best BM, et al. Among authors: kemper ca. J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42. doi: 10.1097/QAI.0b013e318156f029. J Acquir Immune Defic Syndr. 2007. PMID: 17786128 Clinical Trial.

2

The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients.

Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, Tilles JG, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group. Yasuda JM, et al. Among authors: kemper ca. Antivir Ther. 2004 Oct;9(5):753-61. Antivir Ther. 2004. PMID: 15535413 Clinical Trial.

3

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.

Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Tilles JG, Forthal DN, Leedom J, Leibowitz M, McCutchan JA, Richman DD; California Collaborative Treatment Group. Haubrich RH, et al. Among authors: kemper ca. AIDS. 2005 Feb 18;19(3):295-302. AIDS. 2005. PMID: 15718840 Clinical Trial.

4

Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients.

Diamond C, Richardson JL, Milam J, Stoyanoff S, McCutchan JA, Kemper C, Larsen RA, Hollander H, Weismuller P, Bolan R; California Collaborative Trials Group. Diamond C, et al. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):211-8. J Acquir Immune Defic Syndr. 2005. PMID: 15905739

5

A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoring.

Goicoechea M, Vidal A, Capparelli E, Rigby A, Kemper C, Diamond C, Witt MD, Haubrich R; California Collaborative Treatment Group. Goicoechea M, et al. Antivir Ther. 2007;12(1):55-62. Antivir Ther. 2007. PMID: 17503748 Clinical Trial.

6

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S; California Collaborative Treatment Group 578 Team. Goicoechea M, et al. J Infect Dis. 2008 Jan 1;197(1):102-8. doi: 10.1086/524061. J Infect Dis. 2008. PMID: 18171292 Clinical Trial.

7

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team. Karris MY, et al. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e48-50. doi: 10.1097/QAI.0000000000000990. J Acquir Immune Defic Syndr. 2016. PMID: 26977746 Free PMC article. Clinical Trial. No abstract available.

8

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.

Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA; California Collaborative Treatment Group. Haubrich RH, et al. Among authors: kemper ca. AIDS. 2002 Oct 18;16(15):F33-40. doi: 10.1097/00002030-200210180-00001. AIDS. 2002. PMID: 12370520 Clinical Trial.

9

Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

Kemper CA, Haubrich R, Frank I, Dubin G, Buscarino C, McCutchan JA, Deresinski SC; California Collaborative Treatment Group. Kemper CA, et al. J Infect Dis. 2003 Apr 15;187(8):1327-31. doi: 10.1086/374562. Epub 2003 Mar 24. J Infect Dis. 2003. PMID: 12696015 Clinical Trial.

10

Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).

Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH. Wagner GJ, et al. Among authors: kemper ca. AIDS. 2006 Jun 12;20(9):1295-302. doi: 10.1097/01.aids.0000232238.28415.d2. AIDS. 2006. PMID: 16816559 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters